Voyager names senior VP, finance
This article was originally published in Scrip
Voyager Therapeutics, a gene therapy company developing treatments for diseases of the central nervous system, has named Jeff Goater – former vice-president of business development – senior vice-president of finance and business development. In this new role, Mr Goater will be responsible for overseeing finance, business development, and investor and public relations activities across the company. Mr Goater has served as vice-president of business development since the launch of Voyager in 2014. Prior to Voyager, he spent nearly a decade on Wall Street, most recently as a managing director at Evercore Partners.